Your search for oral corticosteroids returned 64 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Older than 2 years remove
News remove

Your search for oral corticosteroids returned 64 results

Sort Results:

Relevant Recent

FDA Approves Nucala for Severe Asthma

The FDA has approved Nucala (mepolizumab; GlaxoSmithKline) for injection as add-on maintenance treatment of patients with severe asthma aged ≥12 years.

What Tests, Txs May Be Unnecessary in Dermatology?

The American Academy of Dermatology has issued new recommendations regarding potentially unnecessary dermatologic tests and treatments as part of the Choosing Wisely campaign.

Asthma Meds Linked to Tx Failure in Older Patients

A study in the American Journal of Respiratory and Critical Care Medicine reports that older asthma patients, particularly those treated with inhaled corticosteroids, appear to be at an increased risk for treatment failure compared to those under the age of 30.

Short- vs. Longer-Duration Corticosteroid Tx for COPD Exacerbations

Currently, COPD guidelines recommend that patients with acute exacerbations be treated with systemic corticosteroids for 7-14 days, however, an updated review suggests that corticosteroid treatment of a shorter duration may be as effective as conventional longer-duration therapy.
Drug News

FDA Panel Says No to OTC Singulair

A panel of expert advisors to the U.S. Food and Drug Administration voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
Drugs in the Pipeline

Phase 3 Study Results for Severe Eosinophilic Asthma Drug

GlaxoSmithKline announced that the primary endpoint for its Phase 3 study of mepolizumab was met for the reduction in the frequency of exacerbations, in patients with severe eosinophilic asthma.